Skip to content

Governor’s Opioid and Substance Use Disorder Advisory Group

Opioid and Substance Use Disorder Advisory Group

Governor Brad Little signed Executive Order 2019-09 on June 13, 2019 creating the Opioid and Substance Use Disorder Advisory Group chaired by the Administrator of the Office of Drug Policy. The group will research, evaluate, and provide the Governor recommendations on streamlining prevention and recovery activities, providing efficiency in battling opioid and substance use and misuse, and eliminating duplicative efforts to more efficiently and effectively fight this epidemic.

Chair — Melinda S. Smyser, Administrator, Office of Drug Policy

Members

  1. A representative of the Department of Health and Welfare — Dave Jeppesen, Director
  2. A representative of the Idaho Board of Medicine — Anne Lawler, Executive Director
  3. A representative of the Idaho Board of Dentistry — Susan Miller, Executive Director
  4. A representative of the Board of Pharmacy — Nicki Chopski, Executive Director
  5. A representative of the Department of Correction — Josh Tewalt, Director
  6. A representative of Idaho State Police Colonel Ked Wills
  7. A representative of the Division of Veterans Services Marv Hagedorn, Administrator
  8. A representative of the State Department of Education — Dr. Eric Studebaker, Director, Student Engagement and Postsecondary Readiness
  9. A member of the Idaho House of Representatives Representative Mike Kingsley
  10. A member of the Idaho Senate Senator Abby Lee
  11. A member of the judiciary — The Hon. Michael Tribe, 5th Judicial District
  12. A county sheriff Rick Henry, Madison County
  13. A county prosecutor — Daniel Clark, Bonneville County
  14. A city police chief — James Fry, Moscow
  15. A representative from the Idaho Indian Tribes — Helo Hancock, CEO Marimn Health, Coeur d’Alene Tribe
  16. A representative of the medical community — Dr. Neil Ragan, HealthWest ISU Community Health Center
  17. A representative of the hospital community Benjamin Smalley, CEO, Cassia Regional Medical Center
  18. A representative of the pharmacy community Dr. Brandon Smith, Jerome Drug
  19. A representative of the treatment community Janice Fulkerson, Director of Contracting and Community Relations, Northpoint Recovery
  20. A representative of the insurance community Dr. Edward McEachern, Chief Medical Officer PacificSource
  21. US Attorney for Idaho or Designee — Bart Davis

Meeting Notices

Next Meeting Wednesday, October 9th in Boise. Time, Agenda, and Exact Location TBD

August 15 meeting minutes published above

Submit Your Ideas

Have ideas or feedback for the Advisory Group? Please submit for consideration.



  • (Optional)


  • (Optional)


  • (Optional)


  • (Optional)


  • This field is for validation purposes and should be left unchanged.
    (Optional)

The Idaho Office of Drug Policy leads Idaho’s substance use and misuse policy and prevention efforts by developing and implementing strategic action plans and collaborative partnerships to reduce drug use and related consequences.

ver: 2.1.0 | last updated: